NI
STJ

Nuance Investments’s St Jude Medical STJ Stock Holding History

Nuance Investments’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-61,744
Closed -$4.95M – 79
2016
Q4 		$4.95M Buy
61,744
+17,434
+39% +$1.38M 0.41% 41
2016
Q3 		$3.53M Sell
44,310
-48,009
-52% -$3.88M 0.35% 34
2016
Q2 		$7.2M Buy
+92,319
New +$6.58M 0.74% 29

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Nuance Investments's STJ Position: Q1 2017 in Review

Nuance Investments sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 61,744 shares — an estimated $4.95M sold.

Nuance Investments first reported a position in STJ in Q2 2016 and held it in 3 quarters. The position peaked at $7.2M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Nuance Investments reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Nuance Investments sold 61,744 St Jude Medical shares in Q1 2017, an estimated $4.95M.
  • Nuance Investments first reported a position in St Jude Medical in Q2 2016 and held it in 3 quarters.
  • Nuance Investments's St Jude Medical position peaked at $7.2M in Q2 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Nuance Investments's 13F filing for Q1 2017, filed 3 May 2017.